Implantable cardioverter-defibrillator implementation in acute heart failure syndromes: unanswered questions.

Journal Article (Journal Article;Review)

Implantable cardioverter-defibrillators have proven efficacy in reducing mortality in patients with reduced left ventricular ejection fraction in both the primary and the secondary prevention settings. All randomized trials demonstrating this benefit have been conducted in outpatients with stable heart failure symptoms. Whether implantable cardioverter-defibrillators confer a benefit when implemented in patients with chronically reduced left ventricular ejection fraction in the acute heart failure setting is unknown. The purpose of this document is to review the existing literature related to this subject.

Full Text

Duke Authors

Cited Authors

  • Wang, NC; Piccini, JP; Gheorghiade, M

Published Date

  • September 2011

Published In

Volume / Issue

  • 16 / 5

Start / End Page

  • 477 - 480

PubMed ID

  • 21424741

Electronic International Standard Serial Number (EISSN)

  • 1573-7322

Digital Object Identifier (DOI)

  • 10.1007/s10741-011-9243-5


  • eng

Conference Location

  • United States